Senior Vice President, Drug Discovery, GlaxoSmithKline
Previously Head of the Division of Medicine and Professor of Clinical Pharmacology, University College London (UCL), Dr. Vallance managed one of the most research-intensive departments of medicine in the UK. He also maintained a practice in general internal medicine, cardiovascular medicine, and clinical pharmacology. He has served on the R&D Advisory Board at GSK since 2004.
His work has been funded by the British Heart Foundation, the Wellcome Trust, and the Medical Research Council, and has been recognised by numerous awards, including the Graham Bull Prize in Clinical Science from the Royal College of Physicians, and by election to the Fellowship of the Academy of Medical Sciences. Currently he is Registrar of the Academy, which seeks to inform public policy regarding healthcare and to translate novel science from bench to bedside. Dr. Vallance has chaired grants committees for the Wellcome Trust, and he serves on the editorial boards of Circulation and of Arteriosclerosis, Thrombosis & Vascular Biology. He has authored more than 200 research papers, review articles, editorials, and textbook chapters.